ID SYIC_HUMAN Reviewed; 1262 AA. AC P41252; A8KAE9; Q5TCD0; Q7Z3T4; Q9H588; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 16-JUN-2009, sequence version 2. DT 27-MAR-2024, entry version 220. DE RecName: Full=Isoleucine--tRNA ligase, cytoplasmic; DE EC=6.1.1.5 {ECO:0000269|PubMed:8052601}; DE AltName: Full=Isoleucyl-tRNA synthetase; DE Short=IRS; DE Short=IleRS; GN Name=IARS1 {ECO:0000312|HGNC:HGNC:5330}; Synonyms=IARS; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=8052601; DOI=10.1073/pnas.91.16.7435; RA Shiba K., Suzuki N., Shigesada K., Schimmel P., Noda T.; RT "Human cytoplasmic isoleucyl-tRNA synthetase: selective divergence of the RT anticodon-binding domain and acquisition of a new structural unit."; RL Proc. Natl. Acad. Sci. U.S.A. 91:7435-7439(1994). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, SUBCELLULAR LOCATION, RP AND VARIANT ILE-769. RC TISSUE=Liver; RX PubMed=7721108; DOI=10.1016/0378-1119(94)00634-5; RA Nichols R.C., Raben N., Boerkoel C.F., Plotz P.H.; RT "Human isoleucyl-tRNA synthetase: sequence of the cDNA, alternative mRNA RT splicing, and the characteristics of an unusually long C-terminal RT extension."; RL Gene 155:299-304(1995). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Trachea; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-1182. RC TISSUE=Colon endothelium; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., RA Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., RA Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., RA Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., RA Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., RA Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., RA Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., RA Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., RA Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., RA Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., RA Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., RA Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., RA McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., RA Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., RA Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., RA Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., RA Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., RA West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., RA Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., RA Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1047, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [8] RP ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19413330; DOI=10.1021/ac9004309; RA Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.; RT "Lys-N and trypsin cover complementary parts of the phosphoproteome in a RT refined SCX-based approach."; RL Anal. Chem. 81:4493-4501(2009). RN [9] RP SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY. RX PubMed=19131329; DOI=10.1074/jbc.m809636200; RA Kaminska M., Havrylenko S., Decottignies P., Gillet S., Le Marechal P., RA Negrutskii B., Mirande M.; RT "Dissection of the structural organization of the aminoacyl-tRNA synthetase RT complex."; RL J. Biol. Chem. 284:6053-6060(2009). RN [10] RP SUBCELLULAR LOCATION, AND SUBUNIT. RX PubMed=19289464; DOI=10.1074/jbc.m900480200; RA Kaminska M., Havrylenko S., Decottignies P., Le Marechal P., Negrutskii B., RA Mirande M.; RT "Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the RT Cytoplasm of Human Cells."; RL J. Biol. Chem. 284:13746-13754(2009). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1047 AND SER-1049, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=20068231; DOI=10.1126/scisignal.2000475; RA Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., RA Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.; RT "Quantitative phosphoproteomics reveals widespread full phosphorylation RT site occupancy during mitosis."; RL Sci. Signal. 3:RA3-RA3(2010). RN [12] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [13] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1047, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [14] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1047 AND THR-1058, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [15] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [16] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=25944712; DOI=10.1002/pmic.201400617; RA Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D., RA Lane L., Bairoch A., Van Dorsselaer A., Carapito C.; RT "N-terminome analysis of the human mitochondrial proteome."; RL Proteomics 15:2519-2524(2015). RN [17] RP VARIANTS TYR-302 AND THR-1188. RX PubMed=24706940; DOI=10.1136/jmedgenet-2013-102218; RG FORGE Canada Consortium; RA Smith A.C., Mears A.J., Bunker R., Ahmed A., MacKenzie M., RA Schwartzentruber J.A., Beaulieu C.L., Ferretti E., Majewski J., RA Bulman D.E., Celik F.C., Boycott K.M., Graham G.E.; RT "Mutations in the enzyme glutathione peroxidase 4 cause Sedaghatian-type RT spondylometaphyseal dysplasia."; RL J. Med. Genet. 51:470-474(2014). RN [18] RP INVOLVEMENT IN GRIDHH, VARIANTS GRIDHH GLY-370; LEU-437; ASP-992 AND RP ASN-1174, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=27426735; DOI=10.1016/j.ajhg.2016.05.027; RA Kopajtich R., Murayama K., Janecke A.R., Haack T.B., Breuer M., RA Knisely A.S., Harting I., Ohashi T., Okazaki Y., Watanabe D., Tokuzawa Y., RA Kotzaeridou U., Koelker S., Sauer S., Carl M., Straub S., Entenmann A., RA Gizewski E., Feichtinger R.G., Mayr J.A., Lackner K., Strom T.M., RA Meitinger T., Mueller T., Ohtake A., Hoffmann G.F., Prokisch H., RA Staufner C.; RT "Biallelic IARS mutations cause growth retardation with prenatal onset, RT intellectual disability, muscular hypotonia, and infantile hepatopathy."; RL Am. J. Hum. Genet. 99:414-422(2016). CC -!- FUNCTION: Catalyzes the specific attachment of an amino acid to its CC cognate tRNA in a 2 step reaction: the amino acid (AA) is first CC activated by ATP to form AA-AMP and then transferred to the acceptor CC end of the tRNA. {ECO:0000269|PubMed:8052601}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L- CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666, CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528, CC ChEBI:CHEBI:456215; EC=6.1.1.5; CC Evidence={ECO:0000269|PubMed:8052601}; CC -!- SUBUNIT: Part of a multisubunit complex that groups tRNA ligases for CC Arg (RARS1), Asp (DARS1), Gln (QARS1), Ile (IARS1), Leu (LARS1), Lys CC (KARS1), Met (MARS1) the bifunctional ligase for Glu and Pro (EPRS1) CC and the auxiliary subunits AIMP1/p43, AIMP2/p38 and EEF1E1/p18 CC (PubMed:19131329, PubMed:19289464). {ECO:0000269|PubMed:19131329, CC ECO:0000269|PubMed:19289464}. CC -!- INTERACTION: CC P41252; P07814: EPRS1; NbExp=7; IntAct=EBI-355303, EBI-355315; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:27426735, CC ECO:0000269|PubMed:7721108}. Cytoplasm, cytosol CC {ECO:0000269|PubMed:19289464}. CC -!- TISSUE SPECIFICITY: Expressed in liver and muscle (at protein level). CC {ECO:0000269|PubMed:27426735}. CC -!- DISEASE: Growth retardation, impaired intellectual development, CC hypotonia, and hepatopathy (GRIDHH) [MIM:617093]: An autosomal CC recessive disorder characterized by severe growth retardation with CC prenatal onset, intellectual disability, muscular hypotonia, and CC hepatic dysfunction. {ECO:0000269|PubMed:27426735}. Note=The disease is CC caused by variants affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAA05835.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D28473; BAA05835.1; ALT_INIT; mRNA. DR EMBL; U04953; AAA80153.1; -; mRNA. DR EMBL; AK293014; BAF85703.1; -; mRNA. DR EMBL; BX537429; CAD97671.1; -; mRNA. DR EMBL; AL136097; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471089; EAW62813.1; -; Genomic_DNA. DR CCDS; CCDS6694.1; -. DR PIR; I59314; I59314. DR RefSeq; NP_002152.2; NM_002161.5. DR RefSeq; NP_038203.2; NM_013417.3. DR AlphaFoldDB; P41252; -. DR SMR; P41252; -. DR BioGRID; 109605; 375. DR ComplexPortal; CPX-2469; Multiaminoacyl-tRNA synthetase complex. DR CORUM; P41252; -. DR IntAct; P41252; 70. DR MINT; P41252; -. DR STRING; 9606.ENSP00000364794; -. DR BindingDB; P41252; -. DR ChEMBL; CHEMBL3235; -. DR DrugBank; DB00167; Isoleucine. DR DrugCentral; P41252; -. DR CarbonylDB; P41252; -. DR GlyGen; P41252; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P41252; -. DR MetOSite; P41252; -. DR PhosphoSitePlus; P41252; -. DR SwissPalm; P41252; -. DR BioMuta; IARS; -. DR DMDM; 239938717; -. DR EPD; P41252; -. DR jPOST; P41252; -. DR MassIVE; P41252; -. DR MaxQB; P41252; -. DR PaxDb; 9606-ENSP00000364794; -. DR PeptideAtlas; P41252; -. DR ProteomicsDB; 55454; -. DR Pumba; P41252; -. DR Antibodypedia; 28131; 150 antibodies from 21 providers. DR DNASU; 3376; -. DR Ensembl; ENST00000375643.7; ENSP00000364794.3; ENSG00000196305.19. DR Ensembl; ENST00000443024.7; ENSP00000406448.4; ENSG00000196305.19. DR Ensembl; ENST00000683565.1; ENSP00000507144.1; ENSG00000196305.19. DR Ensembl; ENST00000707248.1; ENSP00000516807.1; ENSG00000291356.1. DR Ensembl; ENST00000707249.1; ENSP00000516808.1; ENSG00000291356.1. DR Ensembl; ENST00000707251.1; ENSP00000516810.1; ENSG00000291356.1. DR GeneID; 3376; -. DR KEGG; hsa:3376; -. DR MANE-Select; ENST00000443024.7; ENSP00000406448.4; NM_002161.6; NP_002152.2. DR UCSC; uc004art.4; human. DR AGR; HGNC:5330; -. DR CTD; 3376; -. DR DisGeNET; 3376; -. DR GeneCards; IARS1; -. DR HGNC; HGNC:5330; IARS1. DR HPA; ENSG00000196305; Low tissue specificity. DR MalaCards; IARS1; -. DR MIM; 600709; gene. DR MIM; 617093; phenotype. DR neXtProt; NX_P41252; -. DR OpenTargets; ENSG00000196305; -. DR Orphanet; 541423; Growth delay-intellectual disability-hepatopathy syndrome. DR PharmGKB; PA29580; -. DR VEuPathDB; HostDB:ENSG00000196305; -. DR eggNOG; KOG0434; Eukaryota. DR GeneTree; ENSGT00550000074921; -. DR InParanoid; P41252; -. DR OMA; EIIVIHK; -. DR OrthoDB; 656at2759; -. DR PhylomeDB; P41252; -. DR PathwayCommons; P41252; -. DR Reactome; R-HSA-2408522; Selenoamino acid metabolism. DR Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation. DR SignaLink; P41252; -. DR SIGNOR; P41252; -. DR BioGRID-ORCS; 3376; 800 hits in 1127 CRISPR screens. DR ChiTaRS; IARS; human. DR GeneWiki; IARS; -. DR GenomeRNAi; 3376; -. DR Pharos; P41252; Tchem. DR PRO; PR:P41252; -. DR Proteomes; UP000005640; Chromosome 9. DR RNAct; P41252; Protein. DR Bgee; ENSG00000196305; Expressed in cartilage tissue and 211 other cell types or tissues. DR ExpressionAtlas; P41252; baseline and differential. DR GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IDA:UniProtKB. DR GO; GO:0005737; C:cytoplasm; IDA:CAFA. DR GO; GO:0005829; C:cytosol; IDA:UniProtKB. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0051020; F:GTPase binding; IPI:UniProtKB. DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IDA:UniProtKB. DR GO; GO:0000049; F:tRNA binding; IEA:InterPro. DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IDA:UniProtKB. DR GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB. DR GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome. DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1. DR CDD; cd00818; IleRS_core; 1. DR Gene3D; 3.40.50.620; HUPs; 2. DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033709; Anticodon_Ile_ABEc. DR InterPro; IPR002301; Ile-tRNA-ligase. DR InterPro; IPR023586; Ile-tRNA-ligase_type2. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR NCBIfam; TIGR00392; ileS; 1. DR PANTHER; PTHR42780:SF1; ISOLEUCINE--TRNA LIGASE, CYTOPLASMIC; 1. DR PANTHER; PTHR42780; SOLEUCYL-TRNA SYNTHETASE; 1. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF19302; DUF5915; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR PRINTS; PR00984; TRNASYNTHILE. DR SUPFAM; SSF47323; Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases; 1. DR SUPFAM; SSF52374; Nucleotidylyl transferase; 1. DR SUPFAM; SSF50677; ValRS/IleRS/LeuRS editing domain; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. DR Genevisible; P41252; HS. PE 1: Evidence at protein level; KW Acetylation; Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; KW Direct protein sequencing; Disease variant; Intellectual disability; KW Ligase; Nucleotide-binding; Phosphoprotein; Protein biosynthesis; KW Reference proteome. FT CHAIN 1..1262 FT /note="Isoleucine--tRNA ligase, cytoplasmic" FT /id="PRO_0000098597" FT MOTIF 48..58 FT /note="'HIGH' region" FT MOTIF 600..604 FT /note="'KMSKS' region" FT BINDING 603 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0007744|PubMed:19413330" FT MOD_RES 1047 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648, FT ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692, FT ECO:0007744|PubMed:23186163" FT MOD_RES 1049 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:20068231" FT MOD_RES 1058 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:23186163" FT VARIANT 302 FT /note="N -> Y (in dbSNP:rs140666586)" FT /evidence="ECO:0000269|PubMed:24706940" FT /id="VAR_071387" FT VARIANT 370 FT /note="V -> G (in GRIDHH; dbSNP:rs886037876)" FT /evidence="ECO:0000269|PubMed:27426735" FT /id="VAR_077055" FT VARIANT 437 FT /note="P -> L (in GRIDHH; dbSNP:rs886037874)" FT /evidence="ECO:0000269|PubMed:27426735" FT /id="VAR_077056" FT VARIANT 684 FT /note="T -> M (in dbSNP:rs2070053)" FT /id="VAR_058300" FT VARIANT 769 FT /note="M -> I" FT /evidence="ECO:0000269|PubMed:7721108" FT /id="VAR_057951" FT VARIANT 992 FT /note="N -> D (in GRIDHH; dbSNP:rs886037877)" FT /evidence="ECO:0000269|PubMed:27426735" FT /id="VAR_077057" FT VARIANT 1174 FT /note="I -> N (in GRIDHH; dbSNP:rs886037873)" FT /evidence="ECO:0000269|PubMed:27426735" FT /id="VAR_077058" FT VARIANT 1182 FT /note="K -> E (in dbSNP:rs556155)" FT /evidence="ECO:0000269|PubMed:17974005" FT /id="VAR_057952" FT VARIANT 1188 FT /note="M -> T (in dbSNP:rs201071417)" FT /evidence="ECO:0000269|PubMed:24706940" FT /id="VAR_071388" FT CONFLICT 658 FT /note="N -> S (in Ref. 4; CAD97671)" FT /evidence="ECO:0000305" SQ SEQUENCE 1262 AA; 144498 MW; 73CB3967A6868005 CRC64; MLQQVPENIN FPAEEEKILE FWTEFNCFQE CLKQSKHKPK FTFYDGPPFA TGLPHYGHIL AGTIKDIVTR YAHQSGFHVD RRFGWDCHGL PVEYEIDKTL GIRGPEDVAK MGITEYNNQC RAIVMRYSAE WKSTVSRLGR WIDFDNDYKT LYPQFMESVW WVFKQLYDKG LVYRGVKVMP FSTACNTPLS NFESHQNYKD VQDPSVFVTF PLEEDETVSL VAWTTTPWTL PSNLAVCVNP EMQYVKIKDV ARGRLLILME ARLSALYKLE SDYEILERFP GAYLKGKKYR PLFDYFLKCK ENGAFTVLVD NYVKEEEGTG VVHQAPYFGA EDYRVCMDFN IIRKDSLPVC PVDASGCFTT EVTDFAGQYV KDADKSIIRT LKEQGRLLVA TTFTHSYPFC WRSDTPLIYK AVPSWFVRVE NMVDQLLRNN DLCYWVPELV REKRFGNWLK DARDWTISRN RYWGTPIPLW VSDDFEEVVC IGSVAELEEL SGAKISDLHR ESVDHLTIPS RCGKGSLHRI SEVFDCWFES GSMPYAQVHY PFENKREFED AFPADFIAEG IDQTRGWFYT LLVLATALFG QPPFKNVIVN GLVLASDGQK MSKRKKNYPD PVSIIQKYGA DALRLYLINS PVVRAENLRF KEEGVRDVLK DVLLPWYNAY RFLIQNVLRL QKEEEIEFLY NENTVRESPN ITDRWILSFM QSLIGFFETE MAAYRLYTVV PRLVKFVDIL TNWYVRMNRR RLKGENGMED CVMALETLFS VLLSLCRLMA PYTPFLTELM YQNLKVLIDP VSVQDKDTLS IHYLMLPRVR EELIDKKTES AVSQMQSVIE LGRVIRDRKT IPIKYPLKEI VVIHQDPEAL KDIKSLEKYI IEELNVRKVT LSTDKNKYGI RLRAEPDHMV LGKRLKGAFK AVMTSIKQLS SEELEQFQKT GTIVVEGHEL HDEDIRLMYT FDQATGGTAQ FEAHSDAQAL VLLDVTPDQS MVDEGMAREV INRIQKLRKK CNLVPTDEIT VYYKAKSEGT YLNSVIESHT EFIFTTIKAP LKPYPVSPSD KVLIQEKTQL KGSELEITLT RGSSLPGPAC AYVNLNICAN GSEQGGVLLL ENPKGDNRLD LLKLKSVVTS IFGVKNTELA VFHDETEIQN QTDLLSLSGK TLCVTAGSAP SLINSSSTLL CQYINLQLLN AKPQECLMGT VGTLLLENPL GQNGLTHQGL LYEAAKVFGL RSRKLKLFLN ETQTQEITED IPVKTLNMKT VYVSVLPTTA DF //